Search tool

This report examines the triggers and dynamics of drug-related death in the seven EMCDDA Member States with the highest drug-related death (DRD) rates per population. The report explores whether between-country variations might...

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with...

This document gives an overview of the drug-related deaths (DRD) indicator, one of five key epidemiological indicators used by the EMCDDA for the collection and interpretaion of harmonised, good quality data at...

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with...

In May 2015, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone, commonly known as α-pyrrolidinovalerophenone (α-PVP), through a joint assessment. The two organisations concluded that sufficient...

Changing dynamics in the heroin market, the latest implications of cannabis use and new features and dimensions of the stimulant and ‘new drugs’ scene are among the issues highlighted in the European...

The result of the EMCDDA’s cooperation with countries in the Western Balkans over many years, this report is the first of its kind. It gives insight into the drug-related problems faced by...

This paper examines the overall number of lives lost due to drug use. All-cause mortality among problem drug users is investigated by means of cohort studies, which link data from death registries...

Drug-related mortality is a complex phenomenon, which accounts for a considerable percentage of deaths among young people in many European countries. The EMCDDA, in collaboration with national experts, has defined an epidemiological...